Reports - Cell and Gene Therapy Manufacturing Market
Biotechnology and Life SciencesCell and Gene Therapy Manufacturing Market
Cell and Gene Therapy Manufacturing Market Size Analysis Report 2025-2035 by Type (Cell Therapy, Gene Therapy) by Indication (Oncology Diseases, Inherited Disorders, Cardiovascular Diseases, Musculoskeletal Disorders, Neurological Diseases, Other Indications) by Application (Clinical Manufacturing, Commercial Manufacturing) by End User (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations (CMOs), Research Institutes & Academic Centers, Regulatory Agencies, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Global Cell and Gene Therapy Manufacturing Market, 2021 - 2035 (USD Million)
3. Global Cell and Gene Therapy Manufacturing Market - by Type
3.1. By Cell Therapy
3.2. By Gene Therapy
4. Global Cell and Gene Therapy Manufacturing Market - by Indication
4.1. By Oncology Diseases
4.2. By Inherited Disorders
4.3. By Cardiovascular Diseases
4.4. By Musculoskeletal Disorders
4.5. By Neurological Diseases
4.6. By Other Indications
5. Global Cell and Gene Therapy Manufacturing Market - by Application
5.1. By Clinical Manufacturing
5.2. By Commercial Manufacturing
6. Global Cell and Gene Therapy Manufacturing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Contract Manufacturing Organizations (CMOs)
6.3. By Research Institutes & Academic Centers
6.4. By Regulatory Agencies
6.5. By Other End Users
7. Global Cell and Gene Therapy Manufacturing Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. North America Cell and Gene Therapy Manufacturing Market, 2021 - 2035 (USD Million)
3. North America Cell and Gene Therapy Manufacturing Market - by Type
3.1. By Cell Therapy
3.2. By Gene Therapy
4. North America Cell and Gene Therapy Manufacturing Market - by Indication
4.1. By Oncology Diseases
4.2. By Inherited Disorders
4.3. By Cardiovascular Diseases
4.4. By Musculoskeletal Disorders
4.5. By Neurological Diseases
4.6. By Other Indications
5. North America Cell and Gene Therapy Manufacturing Market - by Application
5.1. By Clinical Manufacturing
5.2. By Commercial Manufacturing
6. North America Cell and Gene Therapy Manufacturing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Contract Manufacturing Organizations (CMOs)
6.3. By Research Institutes & Academic Centers
6.4. By Regulatory Agencies
6.5. By Other End Users
Chapter 5 Europe Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Europe Cell and Gene Therapy Manufacturing Market, 2021 - 2035 (USD Million)
3. Europe Cell and Gene Therapy Manufacturing Market - by Type
3.1. By Cell Therapy
3.2. By Gene Therapy
4. Europe Cell and Gene Therapy Manufacturing Market - by Indication
4.1. By Oncology Diseases
4.2. By Inherited Disorders
4.3. By Cardiovascular Diseases
4.4. By Musculoskeletal Disorders
4.5. By Neurological Diseases
4.6. By Other Indications
5. Europe Cell and Gene Therapy Manufacturing Market - by Application
5.1. By Clinical Manufacturing
5.2. By Commercial Manufacturing
6. Europe Cell and Gene Therapy Manufacturing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Contract Manufacturing Organizations (CMOs)
6.3. By Research Institutes & Academic Centers
6.4. By Regulatory Agencies
6.5. By Other End Users
Chapter 6 Asia Pacific Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Asia Pacific Cell and Gene Therapy Manufacturing Market, 2021 - 2035 (USD Million)
3. Asia Pacific Cell and Gene Therapy Manufacturing Market - by Type
3.1. By Cell Therapy
3.2. By Gene Therapy
4. Asia Pacific Cell and Gene Therapy Manufacturing Market - by Indication
4.1. By Oncology Diseases
4.2. By Inherited Disorders
4.3. By Cardiovascular Diseases
4.4. By Musculoskeletal Disorders
4.5. By Neurological Diseases
4.6. By Other Indications
5. Asia Pacific Cell and Gene Therapy Manufacturing Market - by Application
5.1. By Clinical Manufacturing
5.2. By Commercial Manufacturing
6. Asia Pacific Cell and Gene Therapy Manufacturing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Contract Manufacturing Organizations (CMOs)
6.3. By Research Institutes & Academic Centers
6.4. By Regulatory Agencies
6.5. By Other End Users
Chapter 7 Latin America Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Latin America Cell and Gene Therapy Manufacturing Market, 2021 - 2035 (USD Million)
3. Latin America Cell and Gene Therapy Manufacturing Market - by Type
3.1. By Cell Therapy
3.2. By Gene Therapy
4. Latin America Cell and Gene Therapy Manufacturing Market - by Indication
4.1. By Oncology Diseases
4.2. By Inherited Disorders
4.3. By Cardiovascular Diseases
4.4. By Musculoskeletal Disorders
4.5. By Neurological Diseases
4.6. By Other Indications
5. Latin America Cell and Gene Therapy Manufacturing Market - by Application
5.1. By Clinical Manufacturing
5.2. By Commercial Manufacturing
6. Latin America Cell and Gene Therapy Manufacturing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Contract Manufacturing Organizations (CMOs)
6.3. By Research Institutes & Academic Centers
6.4. By Regulatory Agencies
6.5. By Other End Users
Chapter 8 Middle East & Africa Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Middle East & Africa Cell and Gene Therapy Manufacturing Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Cell and Gene Therapy Manufacturing Market - by Type
3.1. By Cell Therapy
3.2. By Gene Therapy
4. Middle East & Africa Cell and Gene Therapy Manufacturing Market - by Indication
4.1. By Oncology Diseases
4.2. By Inherited Disorders
4.3. By Cardiovascular Diseases
4.4. By Musculoskeletal Disorders
4.5. By Neurological Diseases
4.6. By Other Indications
5. Middle East & Africa Cell and Gene Therapy Manufacturing Market - by Application
5.1. By Clinical Manufacturing
5.2. By Commercial Manufacturing
6. Middle East & Africa Cell and Gene Therapy Manufacturing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Contract Manufacturing Organizations (CMOs)
6.3. By Research Institutes & Academic Centers
6.4. By Regulatory Agencies
6.5. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Lonza (Switzerland)
2. Bluebird Bio (U.S.)
3. Catalent Inc. (U.S.)
4. F. Hoffmann-La Roche Ltd. (Switzerland)
5. Samsung Biologics (South Korea)
6. Boehringer Ingelheim (Germany)
7. Cellular Therapeutics (China)
8. Hitachi Chemical Co. Ltd. (Japan)
9. Takara Bio Inc. (Japan)
10. Miltenyi Biotec (U.S.)
11. Thermo Fisher Scientific (U.S.)
12. Novartis International AG (Switzerland)
13. Merck KGaA (Germany)
14. Wuxi Advanced Therapies (U.S.)
15. Fujifilm Holdings Corp. (Japan)
16. Charles River Laboratories International Inc. (U.S.)
17. GE Healthcare Life Sciences (U.S.)
18. CGT Catapult (UK)
19. CoJourney Inc. (China)
20. ElevateBio LLC (U.S.)
21. Pfizer Inc. (U.S.)
22. Incyte Corp. (U.S.)
23. AllogeneTherapeutics Inc. (U.S.)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By